Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for pediatric flexible bronchoscopy
ChiCTR2600133326Phase 4Recruiting
- Sponsor
- Sichuan Provincial Maternal and Child Health Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in bronchopulmonary diseases (2 arms), sponsored by Sichuan Provincial Maternal and Child Health Hospital. Primary endpoint: Perioperative respiratory adverse events. Started Jun 2025; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2600133326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133326.